Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 4 days ago

Korro Bio, Inc.: BALYASNY ASSET MANAGEMENT L.P. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Balyasny Asset Management L.P. amended its Schedule 13G filing for Korro Bio, Inc., disclosing its updated beneficial ownership stake in the biotech company via SEC accession 0001172661-26-005048. The filing reflects a change to the asset manager's previously reported position, though the amended document did not specify the size of the stake or the direction of the change in the headline disclosure. Schedule 13G amendments are typically filed by institutional investors when their ownership crosses or adjusts relative to the 5% threshold, making the update a signal of shifting institutional interest in Korro Bio. Investors will watch for the full filing details to determine whether Balyasny increased or reduced its position and how the move compares with other institutional holders in the stock.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Balyasny Asset Management L.P., Korro Bio, Inc.